Takefumi Suzuki

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Hitoshi Sakurai, Robert R. Bies, T. Scott Stroup et al. · Schizophrenia Bulletin · 2012 · 138 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia

Takefumi Suzuki, Hiroyuki Uchida, Kenji F. Tanaka et al. · The International Journal of Neuropsychopharmacology · 2004 · 130 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16

Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study

H. Takeuchi, Takefumi Suzuki, G. Remington et al. · Schizophrenia Bulletin · 2013 · 112 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Down-regulation of SREBP-1c is associated with the development of burned-out NASH

Tadanobu Nagaya, Naoki Tanaka, Takefumi Suzuki et al. · Journal of Hepatology · 2010 · 104 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +7

Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia

Ariel Graff‐Guerrero, Tarek K. Rajji, Benoit H. Mulsant et al. · JAMA Psychiatry · 2015 · 87 citations

Medicine, Pharmacology, Pharmacotherapy +16